Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

GLAXOSMITHKLINE

  • FDA Approval
  • Feb. 09, 2023, 22:11 UTC
  • 26
  • 0 comments

FDA approve DOSTARLIMAB-GXLY

Comment Full text

APELLIS PHARMS

  • FDA Approval
  • Feb. 09, 2023, 21:26 UTC
  • 30
  • 0 comments

FDA approve PEGCETACOPLAN

Comment Full text

EXELA PHARMA SCIENCE

  • FDA Approval
  • Feb. 09, 2023, 21:16 UTC
  • 26
  • 0 comments

FDA approve FENTANYL CITRATE

Comment Full text

BRISTOL MYERS SQUIBB

  • FDA Approval
  • Feb. 09, 2023, 20:59 UTC
  • 25
  • 0 comments

FDA approve DASATINIB

Comment Full text

REGENERON PHARMACEUTICALS

  • FDA Approval
  • Feb. 09, 2023, 20:59 UTC
  • 25
  • 0 comments

FDA approve AFLIBERCEPT

Comment Full text

JANSSEN PHARMS

  • FDA Approval
  • Feb. 09, 2023, 12:40 UTC
  • 28
  • 0 comments

FDA approve RIVAROXABAN

Comment Full text

JANSSEN PHARMS

  • FDA Approval
  • Feb. 09, 2023, 12:40 UTC
  • 26
  • 0 comments

FDA approve RIVAROXABAN

Comment Full text

TEVA PHARMS USA

  • FDA Approval
  • Feb. 09, 2023, 12:40 UTC
  • 26
  • 0 comments

FDA approve METHYLPHENIDATE HYDROCHLORIDE

Comment Full text

AMNEAL PHARMS

  • FDA Approval
  • Feb. 09, 2023, 12:40 UTC
  • 24
  • 0 comments

FDA approve TRAMADOL HYDROCHLORIDE

Comment Full text

LUPIN LTD

  • FDA Approval
  • Feb. 09, 2023, 12:40 UTC
  • 26
  • 0 comments

FDA approve GLYCOPYRROLATE

Comment Full text
  • Previous
  • 886
  • 887
  • 888
  • 889
  • 890
  • Next

Search

News categories

  • Technical Exchange News(12239)
  • Event(6229)
  • SEC News(265120)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(154640)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin